The future of biology in driving the field of hyperthermia

References

• Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011;144:646–74
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57–70
   PubMed Web of Science ®Google Scholar
• Datta NR, Ordonez SG, Gaipl US, Paulides MM, Crezee H, Gellermann J, et al. Local hyperthermia combined with radiotherapy and/or chemotherapy: Recent advances and promises for the future. Cancer Treat Rev 2015;742:53. PMID2605191
   Google Scholar
• Hurwitz M, Stauffer P. Hyperthermia, radiation and chemotherapy: The role of heat in multidisciplinary cancer care. Semin Oncol 2014;41:714–29
   PubMed Web of Science ®Google Scholar
• Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002;3:487–97
   PubMed Web of Science ®Google Scholar
• Landon CD, Park J, Needham D, Dewhirst MW. Nanoscale drug delivery and hyperthermia: The materials design and preclinical and clinical testing of low temperature-sensitive liposomes used in combination with mild hyperthermia in the treatment of local cancer. Open Nanomed J 2011;3:38–64
   PubMedGoogle Scholar
• Koning GA, Eggermont AMM, Lindner LH, ten Hagen TLM. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharm Res 2010;27:1750–4
   PubMed Web of Science ®Google Scholar
• McDaniel JR, Dewhirst MW, Chilkoti A. Actively targeting solid tumours with thermoresponsive drug delivery systems that respond to mild hyperthermia. Int J Hyperthermia 2013;29:501–10
   PubMed Web of Science ®Google Scholar
• Meyer DE, Shin BC, Kong GA, Dewhirst MW, Chilkoti A. Drug targeting using thermally responsive polymers and local hyperthermia. J Control Release 2001;74:213–24
   PubMed Web of Science ®Google Scholar
• Lindner LH, Hossann M. Factors affecting drug release from liposomes. Curr Opin Drug Discov Devel 2010;13:111–23
   PubMed Web of Science ®Google Scholar
• Nath K, Nelson DS, Heitjan DF, Leeper DB, Zhou R, Glickson JD. Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin. NMR Biomed 2015;28:281–90
   PubMed Web of Science ®Google Scholar
• Lee AH, Tannock IF. Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells. Cancer Res 1998;58:1901–8
   PubMed Web of Science ®Google Scholar
• Leeper DB, Engin K, Thistlethwaite AJ, Hitchon HD, Dover JD, Li DJ, et al. Human tumor extracellular ph as a function of blood-glucose concentration. Int J Radiat Oncol Biol Phys 1994;28:935–43
   PubMed Web of Science ®Google Scholar
• Coss RA, Storck CW, Wells TC, Kulp KA, Wahl M, Leeper DB. Thermal sensitisation by lonidamine of human melanoma cells grown at low extracellular pH. Int J Hyperthermia 2014;30:75–8
   PubMed Web of Science ®Google Scholar
• Nath K, Nelson DS, Heitjan DF, Zhou R, Leeper DB, Glickson JD. Effects of hyperglycemia on lonidamine-induced acidification and de-energization of human melanoma xenografts and sensitization to melphalan. NMR Biomed 2015;28:395–403
   PubMed Web of Science ®Google Scholar
• Ahmed M, Monsky WE, Girnun G, Lukyanov A, D’Ippolito G, Kruskal JB, et al. Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation. Cancer Res 2003;63:6327–33
   PubMed Web of Science ®Google Scholar
• Ahmed M, Goldberg SN. Combination radiofrequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation. Int J Hyperthermia 2004;20:781–802
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Kamel IR, Kruskal JB, Reynolds K, Monsky WL, Stuart KE, et al. Radiofrequency ablation of hepatic tumors: Increased tumor destruction with adjuvant liposomal doxorubicin therapy. Am J Roentgenol 2002;179:93–101
   PubMed Web of Science ®Google Scholar
• Wong C, Stylianopoulos T, Cui JA, Martin J, Chauhan VP, Jiang W, et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci USA 2011;108:2426–31
   PubMed Web of Science ®Google Scholar
• Sen A, Capitano ML, Spernyak JA, Schueckler JT, Thomas S, Singh AK, et al. Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models. Cancer Res 2011;71:3872–80
   PubMed Web of Science ®Google Scholar
• Xu Y, Choi J, Hylander B, Sen A, Evans SS, Kraybill WG, et al. Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin. Int J Hyperthermia 2007;23:513–27
   PubMed Web of Science ®Google Scholar
• Betof AS, Lascola CD, Weitzel D, Landon C, Scarbrough PM, Devi GR, et al. Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise. J Natl Cancer Inst 2015;107:djv040
   PubMedGoogle Scholar
• Jones LW, Antonelli J, Masko EM, Broadwater G, Lascola CD, Fels D, et al. Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer. J Applied Physiol 2012;113:263–72
   PubMed Web of Science ®Google Scholar
• Dayanc BE, Bansal S, Gure AO, Gollnick SO, Repasky EA. Enhanced sensitivity of colon tumour cells to natural killer cell cytotoxicity after mild thermal stress is regulated through HSF1-mediated expression of MICA. Int J Hyperthermia 2013;29:480–90
   PubMed Web of Science ®Google Scholar
• Barnes KD, Shafirstein G, Webber JS, Koonce NA, Harris Z, Griffin RJ. Hyperthermia-enhanced indocyanine green delivery for laser-induced thermal ablation of carcinomas. Int J Hyperthermia 2013;29:474–9
   PubMed Web of Science ®Google Scholar
• Mikucki ME, Fisher DT, Ku AW, Appenheimer MM, Muhitch JB, Evans SS. Preconditioning thermal therapy: Flipping the switch on IL-6 for anti-tumour immunity. Int J Hyperthermia 2013;29:464–73
   PubMed Web of Science ®Google Scholar
• Borges TJ, Lopes RL, Pinho NG, Machado FD, Souza APD, Bonorino C. Extracellular Hsp70 inhibits pro-inflammatory cytokine production by IL-10 driven down-regulation of C/EBP beta and C/EBP delta. Int J Hyperthermia 2013;29:455–63
   PubMed Web of Science ®Google Scholar
• Van Herwijnen MJC, Van der Zee R, Van Eden W, Broere F. Heat shock proteins can be targets of regulatory T cells for therapeutic intervention in rheumatoid arthritis. Int J Hyperthermia 2013;29:448–54
   PubMed Web of Science ®Google Scholar
• Calderwood SK. From stress protein biochemistry to novel immunotherapeutics. Int J Hyperthermia 2013;29:362–3
   PubMed Web of Science ®Google Scholar
• Calderwood SK, Gong J, Stevenson MA, Murshid A. Cellular and molecular chaperone fusion vaccines: Targeting resistant cancer cell populations. Int J Hyperthermia 2013;29:376–9
   PubMed Web of Science ®Google Scholar
• Murshid A, Eguchi T, Calderwood SK. Stress proteins in aging and life span. Int J Hyperthermia 2013;29:442–7
   PubMed Web of Science ®Google Scholar
• Torigoe T, Hirohashi Y, Yasuda K, Sato N. Constitutive expression and activation of stress response genes in cancer stem-like cells/tumour initiating cells: Potent targets for cancer stem cell therapy. Int J Hyperthermia 2013;29:436–41
   PubMed Web of Science ®Google Scholar
• Csoboz B, Balogh GE, Kusz E, Gombos I, Peter M, Crul T, et al. Membrane fluidity matters: Hyperthermia from the aspects of lipids and membranes. Int J Hyperthermia 2013;29:491–9
   PubMed Web of Science ®Google Scholar
• Singh IS, Hasday JD. Fever, hyperthermia and the heat shock response. Int J Hyperthermia 2013;29:423–35
   PubMed Web of Science ®Google Scholar
• Arrigo A-P, Gibert B. Protein interactomes of three stress inducible small heat shock proteins: HspB1, HspB5 and HspB8. Int J Hyperthermia 2013;29:409–22
   PubMed Web of Science ®Google Scholar
• Guzhova IV, Shevtsov MA, Abkin SV, Pankratova KM, Margulis BA. Intracellular and extracellular Hsp70 chaperone as a target for cancer therapy. Int JHyperthermia 2013;29:399–408
   PubMed Web of Science ®Google Scholar
• Epple LM, Bemis LT, Cavanaugh RP, Skope A, Mayer-Sonnenfeld T, Frank C, et al. Prolonged remission of advanced bronchoalveolar adenocarcinoma in a dog treated with autologous, tumour-derived chaperone-rich cell lysate (CRCL) vaccine. Int J Hyperthermia 2013;29:390–8
   PubMed Web of Science ®Google Scholar
• Graner MW, Romanoski A, Katsanis E. The ‘peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity. Int JHyperthermia 2013;29:380–9
   PubMed Web of Science ®Google Scholar
• Mayer-Sonnenfeld T, Har-Noy M, Lillehei KO, Graner MW. Proteomic analyses of different human tumour-derived chaperone-rich cell lysate (CRCL) anti-cancer vaccines reveal antigen content and strong similarities amongst the vaccines along with a basis for CRCL's unique structure: CRCL vaccine proteome leads to unique structure. Int J Hyperthermia 2013;29:520–7
   PubMed Web of Science ®Google Scholar
• Wang X-Y, Subjeck JR. High molecular weight stress proteins: Identification, cloning and utilisation in cancer immunotherapy. Int J Hyperthermia 2013;29:364–75
   PubMed Web of Science ®Google Scholar
• Repasky EA, Evans SS, Dewhirst MW. Temperature matters! And why it should matter to tumor immunologists. Cancer Immunol Res 2013;1:210–16
   PubMed Web of Science ®Google Scholar
• Toraya-Brown S, Fiering S. Local tumour hyperthermia as immunotherapy for metastatic cancer. Int J Hyperthermia 2014;30:531–9
   PubMed Web of Science ®Google Scholar
• Viglianti BL, Dewhirst MW, Boruta RJ, Park JY, Landon C, Fontanella AN, et al. Systemic anti-tumour effects of local thermally sensitive liposome therapy. Int J Hyperthermia 2014;30:385–92
   PubMed Web of Science ®Google Scholar
• Hu Z, Yang XY, Liu Y, Sankin GN, Pua EC, Morse MA, et al. Investigation of HIFU-induced anti-tumor immunity in a murine tumor model. J Transl Med 2007;5:34
   PubMed Web of Science ®Google Scholar
• Waitz R, Solomon SB, Petre EN, Trumble AE, Fasso M, Norton L, et al. Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy. Cancer Res 2012;72:430–9
   PubMed Web of Science ®Google Scholar
• Zerbini A, Pilli M, Penna A, Pelosi G, Schianchi C, Molinari A, et al. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res 2006;66:1139–46
   PubMed Web of Science ®Google Scholar
• Takagi H, Azuma K, Osaki T, Itoh N, Nakazumi S, Taura Y, et al. High temperature hyperthermia treatment for canines exhibiting superficial tumors: A report of three cases. Oncol Lett 2014;8:2055–8
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhai B, Yang W, Yu LX, Dong W, He YQ, et al. Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine. Mol Ther 2009;17:2049–57
   PubMed Web of Science ®Google Scholar
• Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res 2005;127:208–23
   PubMed Web of Science ®Google Scholar
• Kroeze SGC, van Melick HHE, Nijkamp MW, Kruse FK, Kruijssen LWJ, van Diest PJ, et al. Incomplete thermal ablation stimulates proliferation of residual renal carcinoma cells in a translational murine model. BJU Int 2012;110:E281–6
   PubMed Web of Science ®Google Scholar
• Manzoor AA, Lindner LH, Landon CD, Park J-Y, Simnick AJ, Dreher MR, et al. Overcoming Limitations in nanoparticle drug delivery: Triggered, intravascular release to improve drug penetration into tumors. Cancer Res 2012;72:5566–75
   PubMed Web of Science ®Google Scholar
• Fisher DT, Chen Q, Skitzki JJ, Muhitch JB, Zhou L, Appenheimer MM, et al. IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells. J Clin Invest 2011;121:3846–59
   PubMed Web of Science ®Google Scholar
• Appenheimer MM, Chen Q, Girard RA, Wang WC, Evans SS. Impact of fever-range thermal stress on lymphocyte-endothelial adhesion and lymphocyte trafficking. Immunol Investig 2005;34:295–323
   PubMed Web of Science ®Google Scholar
• Haveman J, Geerdink AG, Rodermond HM. Cytokine production after whole body and localized hyperthermia. Int J Hyperthermia 1996;12:791–800
   PubMed Web of Science ®Google Scholar
• Wang XY, Kazim L, Repasky EA, Subjeck JR. Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J Immunol 2001;166:490–7
   PubMed Web of Science ®Google Scholar
• Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012;12(4):252–64
   PubMed Web of Science ®Google Scholar
• Condeelis J, Pollard JW. Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006;124:263–6
   PubMed Web of Science ®Google Scholar
• Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, Stephen TL, Ranganathan A, Deshpande C, et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Investig 2014;124:5466–80
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Ertel BR, Lanphere JA. An important role for granulocytes in the thermal regulation of colon tumor growth. Immunol Invest 2005;34:259–72
   PubMed Web of Science ®Google Scholar
• Capitano ML, Ertel BR, Repasky EA, Ostberg JR. Winner of the 2007 Society for Thermal Medicine Young Investigator Award. Fever-range whole body hyperthermia prevents the onset of type 1 diabetes in non-obese diabetic mice. Int J Hyperthermia 2008;24:141–9
   PubMed Web of Science ®Google Scholar
• Lee CT, Kokolus KM, Leigh ND, Capitano M, Hylander BL, Repasky EA. Defining immunological impact and therapeutic benefit of mild heating in a murine model of arthritis. PLoS One 2015;10:e0120327
   PubMed Web of Science ®Google Scholar
• Aird KM, Allensworth JL, Batinic-Haberle I, Lyerly HK, Dewhirst MW, Devi GR. ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells. Breast Cancer Res Treat 2012;132:109–19
   PubMed Web of Science ®Google Scholar
• Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis 2009;30:1073–81
   PubMed Web of Science ®Google Scholar
• Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem-Biol Interact 2006;160:1–40
   PubMed Web of Science ®Google Scholar
• Ali F, Sultana S. Repeated short-term stress synergizes the ROS signalling through up regulation of NFkB and iNOS expression induced due to combined exposure of trichloroethylene and UVB rays. Mol Cell Biochem 2012;360:133–45
   PubMed Web of Science ®Google Scholar
• Gorlach A, Berchner-Pfannschmidt U, Wotzlaw C, Cool RH, Fandrey J, Acker H, et al. Reactive oxygen species modulate HIF-1 mediated PAI-1 expression: Involvement of the GTPase Rac1. Thromb Haemost 2003;89:926–35
   PubMed Web of Science ®Google Scholar
• Li F, Sonveaux P, Rabbani ZN, Liu S, Yan B, Huang Q, et al. Regulation of HIF-1 alpha stability through S-nitrosylation. Mol Cell 2007;26:63–74
   PubMed Web of Science ®Google Scholar
• Semenza GL. Mechanisms of disease oxygen sensing, homeostasis, and disease. N Engl J Med 2011;365:537–47
   PubMed Web of Science ®Google Scholar
• Dewhirst MW. Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress. Radiat Res 2009;172:653–65
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Cao Y, Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 2008;8:425–37
   PubMed Web of Science ®Google Scholar
• Ye XD, Fels D, Tovmasyan A, Aird KM, Dedeugd C, Allensworth JL, et al. Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate. Free Radic Res 2011;45:1289–306
   PubMed Web of Science ®Google Scholar
• Slimen IB, Najar T, Ghram A, Dabbebi H, Ben Mrad M, Abdrabbah M. Reactive oxygen species, heat stress and oxidative-induced mitochondrial damage. A review. Int J Hyperthermia 2014;30:513–23
   PubMed Web of Science ®Google Scholar
• Davidson JF, Whyte B, Bissinger PH, Schiestl RH. Oxidative stress is involved in heat-induced cell death in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 1996;93:5116–21
   PubMed Web of Science ®Google Scholar
• Mitchell JB, Russo A. Thiols, thiol depletion, and thermosensitivity. Radiat Res 1983;95:471–85
   PubMed Web of Science ®Google Scholar
• Laskowitz DT, Elion GB, Dewhirst MW, Griffith OW, Casero RA, Scott PA, et al. effects of glutathione or polyamine depletion on in vivo thermosensitization. Int J Hyperthermia 1992;8:199–208
   PubMed Web of Science ®Google Scholar
• Moon EJ, Sonveaux P, Porporato PE, Danhier P, Gallez B, Batinic-Haberle I, et al. NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment. Proc Natl Acad Sci USA 2010;107:20477–82
   PubMed Web of Science ®Google Scholar
• Nie W, Ma XL, Sang YX, Li YL, Gao X, Xu GC, et al. Synergic antitumor effect of SKLB1002 and local hyperthermia in 4T1 and CT26. Clin Exper Med 2014;14:203–13
   PubMed Web of Science ®Google Scholar
• Chen P, Yang LL, Yang HS, Wang YS, Li G, Wu Y, et al. Synergistic antitumor effect of CXCL10 with hyperthermia. J Cancer Res Clin Oncol 2008;134:679–87
   PubMed Web of Science ®Google Scholar
• Roca C, Primo L, Vaidembri D, Cividalli A, Declerck P, Carmeliet P, et al. Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism. Cancer Res 2003;63:1500–7
   PubMed Web of Science ®Google Scholar
• Moon EJ, Brizel DM, Chi JTA, Dewhirst MW. The potential role of intrinsic hypoxia markers as prognostic variables in cancer. Antioxid Redox Signal 2007;9:1237–94
   PubMed Web of Science ®Google Scholar
• Cao W, Xu X, Zhang JL, Duan YY. Tumor angiogenesis after heated lipiodol infusion via the hepatic artery in a rabbit model of VX2 liver cancer. PLoS One 2013;8:e61583
   PubMed Web of Science ®Google Scholar
• Kong J, Kong JG, Pan B, Ke S, Dong SY, Li XL, et al. Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1 alpha/VEGFA. PLoS One 2012;7(5)
   Web of Science ®Google Scholar
• Nikfarjam M, Muralidharan V, Christophi C. Altered growth patterns of colorectal liver metastases after thermal ablation. Surgery. 2006;139:73–81
   PubMed Web of Science ®Google Scholar
• Gong B, Asimakis GK, Chen ZP, Albrecht TB, Boor PJ, Pappas TC, et al. Whole-body hyperthermia induces up-regulation of vascular endothelial growth factor accompanied by neovascularization in cardiac tissue. Life Sci 2006;79:1781–8
   PubMed Web of Science ®Google Scholar
• Krawczyk PM, Eppink B, Essers J, Stap J, Rodermond H, Odijk H, et al. Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. Proc Natl Acad Sci USA. 2011;108:9851–6
   PubMed Web of Science ®Google Scholar
• Pelicci PG, Dalton P, Orecchia R. Heating cancer stem cells to reduce tumor relapse. Breast Cancer Res 2011;13:305
   PubMed Web of Science ®Google Scholar
• Atkinson RL, Zhang M, Diagaradjane P, Peddibhotla S, Contreras A, Hilsenbeck SG, et al. Thermal Enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. Sci Transl Med 2010;2:55ra79
   PubMed Web of Science ®Google Scholar
• Lee H, Park HJ, Park CS, Oh ET, Choi BH, Williams B, et al. Response of breast cancer cells and cancer stem cells to metformin and hyperthermia alone or combined. PLoS One 2014;9(2):e87979
   PubMed Web of Science ®Google Scholar
• Yang Y, Qu B, Huo JH, Wu SL, Zhang MY, Wang ZR. Serum from radiofrequency-injured livers induces differentiation of bone marrow stem cells into hepatocyte-like cells. J Surg Res 2009;155:18–24
   PubMed Web of Science ®Google Scholar
• Ahn GO, Tseng D, Liao CH, Dorie MJ, Czechowicz A, Brown JM. Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc Natl Acad Sci USA 2010;107:8363–8
   PubMed Web of Science ®Google Scholar
• Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 2010;120:694–705
   PubMed Web of Science ®Google Scholar
• Capitano ML, Nemeth MJ, Mace TA, Salisbury-Ruf C, Segal BH, McCarthy PL, et al. Elevating body temperature enhances hematopoiesis and neutrophil recovery after total body irradiation in an IL-1-, IL-17-, and G-CSF-dependent manner. Blood 2012;120:2600–9
   PubMed Web of Science ®Google Scholar
• Tamulevicius P, Gobel D, Streffer C. Effect of hyperthermia on energy-metabolism in vivo. Strahlentherapie 1983;159:383–4
   Google Scholar
• Tamulevicius P, Streffer C. Bioluminescence imaging of metabolites in a human tumour xenograft after treatment with hyperthermia and/or the radiosensitizer pimonidazole. Int J Hyperthermia 1997;13:235–45
   PubMed Web of Science ®Google Scholar
• Lee SY, Ryu KH, Kang MS, Song CW. Effect of hyperthermia on the lactic acid and beta-hydroxybutyric acid content in tumour. Int J Hyperthermia 1986;2:213–22
   PubMedGoogle Scholar
• Bowden SD, Rowley G, Hinton JCD, Thompson A. Glucose and glycolysis are required for the successful infection of macrophages and mice by Salmonella enterica serovar Typhimurium. Infect Immun 2009;77:3117–26
   PubMed Web of Science ®Google Scholar
• Fifis T, Gamvrellis A, Crimeen-Irwin B, Pietersz GA, Li J, Mottram PL, et al. Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors. J Immunol 2004;173:3148–54
   PubMed Web of Science ®Google Scholar
• Hadrup SR, Bakker AH, Shu CJ, Andersen RS, van Veluw J, Hombrink P, et al. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat Methods 2009;6:520–6
   PubMed Web of Science ®Google Scholar
• Peek LJ, Middaugh CR, Berkland C. Nanotechnology in vaccine delivery. Adv Drug Del Rev 2008;60(8):915–28
   PubMed Web of Science ®Google Scholar
• Ito A, Matsuoka F, Honda H, Kobayashi T. Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticles. Cancer Gene Ther 2003;10:918–25
   PubMed Web of Science ®Google Scholar
• Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005;26:3995–4021
   PubMed Web of Science ®Google Scholar
• Ito A, Shinkai M, Honda H, Kobayashi T. Medical application of functionalized magnetic nanoparticles. J] Biosci Bioeng 2005;100:1–11
   PubMed Web of Science ®Google Scholar
• Jordan A, Scholz R, Wust P, Fahling H, Felix R. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mat 1999;201:413–19
   Web of Science ®Google Scholar
• Mornet S, Vasseur S, Grasset F, Duguet E. Magnetic nanoparticle design for medical diagnosis and therapy. J Mater Chem 2004;14:2161–75
   Web of Science ®Google Scholar
• Neuberger T, Schopf B, Hofmann H, Hofmann M, von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J Magn Magn Mater 2005;293:483–96
   Web of Science ®Google Scholar
• Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 2003;36:R167–81
   Web of Science ®Google Scholar
• Skrabalak SE, Chen JY, Sun YG, Lu XM, Au L, Cobley CM, et al. Gold nanocages: Synthesis, properties, and applications. Accounts Chem Res 2008;41:1587–95
   PubMed Web of Science ®Google Scholar
• Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids – physical evaluation of their potential for hyperthermia. Int J Hyperthermia 1993;9:51–68
   PubMed Web of Science ®Google Scholar
• Dewhirst MW. Hyperthermia and nanotechnology – a note from the Editor-in-chief. Int J Hyperthermia 2008;24:449–50
   PubMed Web of Science ®Google Scholar
• Ivkov R. Magnetic nanoparticle hyperthermia: A new frontier in biology and medicine? Int J Hyperthermia 2013;29:703–5
   PubMed Web of Science ®Google Scholar
• Tarner IH, Muller-Ladner U, Uhlemann C, Lange U. The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis. Clin Rheumatol 2009;28:397–402
   PubMed Web of Science ®Google Scholar
• Tulapurkar ME, Hasday JD, Singh IS. Prolonged exposure to hyperthermic stress augments neutrophil recruitment to lung during the post-exposure recovery period. Int J Hyperthermia 2011;27:717–25
   PubMed Web of Science ®Google Scholar